Activity Dates: 11/01/2017 - 12/31/2019
This activity has been developed and designed for pharmacists who are preparing to sit for the Board of Pharmacy Specialty (BPS) exam in Psychiatric Pharmacy as they strive to obtain the credentials of Board Certified Psychiatric Pharmacist (BCPP).
This BCPP prep product includes 11 recorded review webinars and one "last-chance" question and answer session with authors/presenters immediately before the Board of Pharmacy Specialties spring and fall testing windows.
Question and Answer Session: The live, last chance Q&A conference calls were held prior to the spring and fall testing windows. The conference call allowed participants the opportunity to ask questions of the Review Course editors immediately prior to BPS spring testing window. The conference call recordings are available below.
Webinars: The recorded webinar presentations are structured to provide a review of the major topics in the psychiatric pharmacy domains as specified by the BCPP Specialty Council in the current edition of the BPS Candidate's Guide. Webinars feature case-based self-assessment questions with feedback. To obtain optimal benefit, the participant should also purchase the Psychiatric Pharmacotherapy Review Book (check out the bundle cost savings) and have reviewed the chapter for the specified disease state before listening to the recorded presentation. The presenter will be referring the participant back to the chapter for complete details on some items.
AAPP has invested in supporting the most popular web browsers and leveraging software that our members use daily. Beyond PDF downloads, the rest of the system is built on HTML5, a technology that most up-to-date browsers will support. To access AAPP course materials online, you will need:
AAPP web sites no longer fully support Microsoft Internet Explorer or Windows 8.1 and older. We cannot guarantee that the site will function perfectly on every device and configuration, but using the latest version of the software above will greatly improve your experience.
Jolene Bostwick, PharmD, BCPS, BCPP
Associate Chair & Clinical Associate Professor, Department of Clinical Pharmacy No Relevant Financial Relationships to Disclose My presentation will include discussion of off-label, experimental, and /or investigational use of drugs or devices: psychotropics used to treat psychiatric comorbidities. May be others; however, information will be based on published literature and will be clearly stated the medications are off-label |
Joshua Caballero, PharmD, BCPP, FCCP
Professor No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: psychotropics used to treat psychiatric comorbidities. May be others; however, information will be based on published literature and will be clearly stated the medications are off-label |
Ryan Carnahan, PharmD, MS, BCPP
Associate Professor No Relevant Financial Relationships to Disclose |
Lisa W. Goldstone, PharmD, MS, BCPS, BCPP
Associate Professor of Clinical Pharmacy No Relevant Financial Relationships to Disclose |
Cynthia A. Gutierrez, PharmD, MS, BCPP
Clinical Pharmacy Program Manager, Mental Health No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: Lithium, triiodothyronine, buspirone, risperidone as augmentation strategies for depression |
Calleen Lavinghousez, PharmD, BCPS, BCPP
VISN 7 Academic Detailing Pharmacist, Mental Health Clinical Pharmacy Specialist No Relevant Financial Relationships to Disclose Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: gabapentin |
Megan Maroney, PharmD, BCPP
Clinical Associate Professor No Relevant Financial Relationships to Disclose External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Janssen Connect (division of Janssen Pharmaceuticals); Speakers Bureau: Otsuka-Lundbeck EXCEL Speaker's Bureau |
Sandra Mullen, PharmD, BCPP
Clinical Pharmacy Specialist-Psychiatry Other Financial or Material Support: CVS/pharmacy employee stock Presentation will include discussion of off-label, experimental, and/or investigational use of drugs or devices: bupropion, imipramine, desipramine, and notriptyline, immediate-release alpha-agonists for ADHD. Stimulants and second generation antipsychotics for ODD/CD. Anitdepressants, mood stabilizers, alpha agonists for autism spectrum disorders |
Carol Ott, PharmD, BCPP
Clinical Professor of Pharmacy Practice External Consultant Activities, Advisory Panels, Speakers Bureaus, etc.: Indiana Attorney General's Office - case consultation, Tippecanoe County (Indiana) Public Defender's Office - case consultation, Psychopharmacology Consultation Team - Indiana University - Department of Child Services |
Kimberly Tallian, PharmD, BCPP, FASHP, FCCP, FCSHP
Psychiatry Pharmacy Specialist No Relevant Financial Relationships to Disclose |
Traci Turner, PharmD, BCPP
Clinical Pharmacy Specialist No Relevant Financial Relationships to Disclose |
Topic |
---|
Anxiety and Anxiety-Related Disorders
Author: Jolene Bostwick, PharmD, BCPS, BCPP
|
Biostatistics and Research Design in Psychiatry
Author: Ryan M. Carnahan, PharmD, MS, BCPP
|
Bipolar Disorder
Author: Carol Ott, PharmD, BCPP
|
Depression
Author: Cynthia A. Gutierrez, PharmD, MS, BCPP
|
Neurocognitive Disorders
Author: Joshua Caballero, PharmD, BCPP
|
Neurodevelopmental, Disruptive, Impulse-Control and Conduct Disorders
Author: Sandra Mullen, PharmD, BCPP
|
Neurologic Disorders
Author: Kimberly Tallian, PharmD, APH, BCPP, FASHP, FCCP, FCSHP
|
Personality Disorders and Eating Disorders
Author: Traci Turner, PharmD, BCPP
|
Schizophrenia Spectrum and Other Psychotic Disorders
Author: Lisa W. Goldstone, MS, LPC, PharmD, BCPS, BCPP
|
Sleep-Wake Disorders
Author: Megan Maroney, PharmD, BCPP
|
Substance-Related Disorders
Author: Calleen Lavinghousez, PharmD, BCPS, BCPP
|
AAPP owns the copyright, is licensed or has received permissions for use of, or is otherwise permitted to use copyrighted materials within any CPE activity. Authors and speakers are required to obtain necessary copyright permissions for content in CPE activities. AAPP complies with copyright laws and regulations.
This activity may include discussions of products or devices that are not currently approved for use by the Food and Drug Administration (FDA), or are currently investigational.
In accordance with the Food and Drug Administration (FDA), it is disclosed that there is the potential for discussions concerning off-label uses of a commercial product/devices during this educational activity.
Any person who may contribute to the content of this continuing education activity must disclose significant relationships (and any known relationships of their spouse/partner) with commercial companies whose products or services are discussed in this activity. Significant relationships include receiving from a commercial company research grants, consultant fees, travel, other benefits, or having a self-managed equity interest in a company.
Disclosure of a relationship is not intended to suggest or condone any bias in any presentation but is made to provide participants with information that might be of potential importance to their evaluation of a presentation.
It is the policy of AAPP to ensure independence, balance, objectivity, scientific rigor, and integrity in continuing education activities. Those involved in the development of this continuing education activity have made all reasonable efforts to ensure that information contained herein is accurate in accordance with the latest available scientific knowledge at the time of accreditation of this continuing education activity. Information regarding drugs (e.g., their administration, dosages, contraindications, adverse reactions, interactions, special warnings, and precautions) and drug delivery systems is subject to change, however, and the reader is advised to check the manufacturer’s package insert for information concerning recommended dosage and potential problems or cautions prior to dispensing or administering the drug or using the drug delivery systems.
Fair balance is achieved through ongoing and thorough review of all materials produced by faculty, and all educational and advertising materials produced by supporting organizations, prior to educational offerings. Approval of credit for this continuing education activity does not imply endorsement by AAPP for any product or manufacturer identified.